Opinion|Videos|January 29, 2025

Patient Experiences, Key Clinical Trial Outcomes of the Port Delivery System

2

Panelists discuss how the Port Delivery System (PDS) presents important considerations around adverse effects, patient selection criteria, and adoption challenges including surgical requirements and cost-benefit analyses that must be carefully weighed when integrating this technology into retinal practice.

Video content above is prompted by the following:

  • Could you discuss the key outcomes from the ARCHWAY trial for PDS?
  • The PDS Q24W was noninferior to monthly ranibizumab in terms of BCVA change from baseline

Newsletter


Latest CME